Latest Breaking News On - Serge belanger needham company analyst - Page 1 : vimarsana.com

BioCryst Pharmaceuticals (BCRX) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. BioCryst Pharmaceuticals (NASDAQ: BCRX) Ladies and gentlemen, thank you for standing by, and welcome to the BioCryst s first-quarter 2021 earnings call. [Operator instructions] I would now like to hand the conference over to your speaker today, Mr. John Bluth of BioCryst. John, the floor is yours. John Bluth Senior Vice President, Investor Relations and Corporate Communications Thanks, Jay. Good morning and welcome to BioCryst s first-quarter 2021 corporate update and financial results conference call. Today s press release is available on our website. Participating with me today are CEO, Jon Stonehouse; CFO, Anthony Doyle; and chief commercial officer, Charlie Gayer; chief medical officer, Dr.

United kingdomJohn bluthAllen hodgesBill sheridanKenny chanAnthony doyleCharlie gayerGena wangKenny chan jefferiesJessica fyeMegan sniecinskiBrian abrahamsLiisa baykoSerge belangerAmerica merrill lynchAlan hodges